EQRx, Inc.
EQRXNASDAQHealthcare
$2.34
$-0.05(-2.09%)
Market Cap$1.1B
P/E Ratio—
52W High$4.75
52W Low$1.58
EQRx, Inc. (EQRX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EQRX · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 9, 2023EPS Actual
-$0.18
Est. -$0.16 · -12.5%
Revenue
—
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 9, 2023
After Market Close
▼ Miss EPS
EQRX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$78.12
Rev. $1025.0B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$78.12
Rev. Est.$1025.0B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 9, 2023 | -$0.16 | -$0.18 | -12.5% | — | — | — |
| ▼ Q3 FY2023 | Aug 8, 2023 | -$0.11 | -$0.15 | -36.4% | — | — | — |
| ▼ Q2 FY2023 | May 8, 2023 | -$0.12 | -$0.17 | -41.7% | — | — | — |
| ▲ Q1 FY2023 | Feb 23, 2023 | -$0.19 | -$0.05 | +73.7% | — | — | — |
| ▲ Q4 FY2022 | Nov 10, 2022 | -$0.21 | -$0.18 | +14.3% | — | — | — |
| ▲ Q3 FY2022 | Aug 11, 2022 | -$0.20 | -$0.16 | +20.0% | — | — | — |
| ▲ Q2 FY2022 | May 13, 2022 | -$0.25 | -$0.17 | +32.0% | — | — | — |
| — Q1 FY2022 | Mar 23, 2022 | — | $0.00 | — | — | — | — |
Q4 FY2023
Nov 9, 2023Miss
EPS Actual
-$0.18
EPS Est.
-$0.16
EPS Surpr.
-12.5%
Revenue
—
Q3 FY2023
Aug 8, 2023Miss
EPS Actual
-$0.15
EPS Est.
-$0.11
EPS Surpr.
-36.4%
Revenue
—
Q2 FY2023
May 8, 2023Miss
EPS Actual
-$0.17
EPS Est.
-$0.12
EPS Surpr.
-41.7%
Revenue
—
Q1 FY2023
Feb 23, 2023Beat
EPS Actual
-$0.05
EPS Est.
-$0.19
EPS Surpr.
+73.7%
Revenue
—
Q4 FY2022
Nov 10, 2022Beat
EPS Actual
-$0.18
EPS Est.
-$0.21
EPS Surpr.
+14.3%
Revenue
—
Q3 FY2022
Aug 11, 2022Beat
EPS Actual
-$0.16
EPS Est.
-$0.20
EPS Surpr.
+20.0%
Revenue
—
Q2 FY2022
May 13, 2022Beat
EPS Actual
-$0.17
EPS Est.
-$0.25
EPS Surpr.
+32.0%
Revenue
—
Q1 FY2022
Mar 23, 2022
EPS Actual
$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 0 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 0 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 0 |
| Q4 FY2023 | $-0.20 | $-0.20 | $-0.20 | 1 |
| Q3 FY2023 | $-0.16 | $-0.16 | $-0.16 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 9, 2023 | -12.5% | $2.34 | $2.34 | +0.00% |
| ▼ Q3 FY2023 | Aug 8, 2023 | -36.4% | $2.22 | $2.24 | +0.90% |
| ▼ Q2 FY2023 | May 8, 2023 | -41.7% | $1.85 | $1.84 | -0.54% |
| ▲ Q1 FY2023 | Feb 23, 2023 | +73.7% | $2.18 | $2.21 | +1.38% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +14.3% | $5.45 | $3.89 | -28.62% |
| ▲ Q3 FY2022 | Aug 11, 2022 | +20.0% | $5.99 | $4.72 | -21.20% |
| ▲ Q2 FY2022 | May 13, 2022 | +32.0% | $3.31 | $4.11 | +24.17% |
| — Q1 FY2022 | Mar 23, 2022 | — | $3.97 | $3.90 | -1.76% |
Q4 FY2023+0.00%
Report Date
Nov 9, 2023
EPS Beat/Miss
-12.5%
Price Before
$2.34
Price After
$2.34
Q3 FY2023+0.90%
Report Date
Aug 8, 2023
EPS Beat/Miss
-36.4%
Price Before
$2.22
Price After
$2.24
Q2 FY2023-0.54%
Report Date
May 8, 2023
EPS Beat/Miss
-41.7%
Price Before
$1.85
Price After
$1.84
Q1 FY2023+1.38%
Report Date
Feb 23, 2023
EPS Beat/Miss
+73.7%
Price Before
$2.18
Price After
$2.21
Q4 FY2022-28.62%
Report Date
Nov 10, 2022
EPS Beat/Miss
+14.3%
Price Before
$5.45
Price After
$3.89
Q3 FY2022-21.20%
Report Date
Aug 11, 2022
EPS Beat/Miss
+20.0%
Price Before
$5.99
Price After
$4.72
Q2 FY2022+24.17%
Report Date
May 13, 2022
EPS Beat/Miss
+32.0%
Price Before
$3.31
Price After
$4.11
Q1 FY2022-1.76%
Report Date
Mar 23, 2022
EPS Beat/Miss
—
Price Before
$3.97
Price After
$3.90
Avg Beat Reaction-6.07%
Avg Miss Reaction+0.12%
Beat Rate4 / 8 quarters
Largest Move-28.62% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EQRX ends December
EQRx, Inc. (EQRX) most recently reported earnings on November 9, 2023 for Q4 FY2023, posting EPS of $-0.18 — missing the analyst consensus of $-0.16 by -12.5%. The next EQRX earnings date is expected around September 1, 2026.
Each quarter, investors track EQRX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EQRX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EQRX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EQRX earnings · 5 questionsEQRx, Inc.'s next earnings report is expected around September 1, 2026. EQRX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EQRX historically reports after market close (AMC).
EQRX earnings datewhen is EQRX earningsEQRX next earnings datewhen does EQRX report earningsEQRX earnings calendar
▸ Source: FMP · EQRx, Inc. SEC filings · US GAAP · EQRx, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026